Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP513046.RAeOQSXoK6pXMQygBPzMEWoHIQiJQxK40rOQ3hkA-lM_k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP513046.RAeOQSXoK6pXMQygBPzMEWoHIQiJQxK40rOQ3hkA-lM_k130_assertion type Assertion NP513046.RAeOQSXoK6pXMQygBPzMEWoHIQiJQxK40rOQ3hkA-lM_k130_head.
- NP513046.RAeOQSXoK6pXMQygBPzMEWoHIQiJQxK40rOQ3hkA-lM_k130_assertion description "[The genotypes at polymorphic sites of the glutathione S-transferase (GST) M1 (null/wildtype) and P1 (nucleotide 2627 A/G), myeloperoxidase (MPO) (nucleotide -463 G/A), X-ray repair cross-complementing group 1 (XRCC1) (nucleotides 26304 C/T; 28152 G/A), and NADPH quinine oxidoreductase (NQO1) (nucleotide 609 C/T) genes in 75 Chinese patients with non-small cell lung cancer (NSCLC) were characterized with polymerase chain reaction-restriction fragment length polymorphism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP513046.RAeOQSXoK6pXMQygBPzMEWoHIQiJQxK40rOQ3hkA-lM_k130_provenance.
- NP513046.RAeOQSXoK6pXMQygBPzMEWoHIQiJQxK40rOQ3hkA-lM_k130_assertion evidence source_evidence_literature NP513046.RAeOQSXoK6pXMQygBPzMEWoHIQiJQxK40rOQ3hkA-lM_k130_provenance.
- NP513046.RAeOQSXoK6pXMQygBPzMEWoHIQiJQxK40rOQ3hkA-lM_k130_assertion SIO_000772 16157195 NP513046.RAeOQSXoK6pXMQygBPzMEWoHIQiJQxK40rOQ3hkA-lM_k130_provenance.
- NP513046.RAeOQSXoK6pXMQygBPzMEWoHIQiJQxK40rOQ3hkA-lM_k130_assertion wasDerivedFrom befree-2016 NP513046.RAeOQSXoK6pXMQygBPzMEWoHIQiJQxK40rOQ3hkA-lM_k130_provenance.
- NP513046.RAeOQSXoK6pXMQygBPzMEWoHIQiJQxK40rOQ3hkA-lM_k130_assertion wasGeneratedBy ECO_0000203 NP513046.RAeOQSXoK6pXMQygBPzMEWoHIQiJQxK40rOQ3hkA-lM_k130_provenance.